Regeneron Pharmaceuticals Shares Rise After UBS Upgrade

MT newswire2026/10/15 19:12

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

03:12 PM EDT, 10/15/2026 (MT Newswires) -- Regeneron Pharmaceuticals (REGN) shares rose 2.8% in Thursday trading after UBS upgraded the stock to buy from neutral and raised its price target to $978 from $660 earlier. Trading volume stood at over 557,000 shares, compared with a daily average of about 743,000. Price: 800.39, Change: +22.03, Percent Change: +2.83

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Regeneron Pharmaceuticals Shares Rise After UBS Upgrade

You may also like

Crypto prices